semaglutide + cagrilintide & in Overweight Adults (REDEFINE-1) | NEJM ADA: Once-weekly cagrilintide + semaglutide

*Truemed is for qualified customers

For gut health, tendon repair, and whole-body inflammation, it may be one of the most promising tools weve seen in years

Lilly has demonstrated their ability to bring complex peptide therapies through the regulatory process, and their phase 3 TRIUMPH trial program for retatrutide includes multiple studies across different patient populations

The most consequential open safety question with TB-500 relates to its angiogenic mechanism: any compound that promotes new blood vessel growth carries a theoretical consideration around active or undiagnosed cancer, since tumours also depend on angiogenesis